Unibest 优贝德
← Back to patent-cliff list

恩格列净

Tier A — Act now

Empagliflozin · all drugs expiring in 2028 →

Boehringer Ingelheim International Gmbh
Originator
2014
First approval
2028
Expiry (public)
$5.97B ▲
Peak sales
化学药
Type

TargetsSGLT2

BrandJardiance、Gibtulio、Oboravo、欧唐静

Indications (approved)慢性肾功能不全、心脏衰竭、二型糖尿病

Regional status

US
批准上市
2014-08-01
EU
批准上市
2014-05-22
China
批准上市
2017-09-20
Japan
批准上市
2014-12-26

Synthetic routes & intermediates3 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 1

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 8 · Total yield 0.12 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
EMPA-00121739-92-4Available5-bromo-2-chlorobenzoic acid
EMPA-002100-66-3Availableanisole
EMPA-003333361-49-2Available(5-bromo-2-chlorophenyl)(4-methoxyphenyl)methanone
EMPA-004333361-51-6Available4-bromo-1-chloro-2-(4-methoxybenzyl)benzene
EMPA-005864070-18-8Available4-(5-bromo-2-chlorobenzyl)phenol
EMPA-006864070-19-9Available(4-(5-bromo-2-chlorobenzyl)phenoxy)(tert-butyl)dimethylsilane
EMPA-00732384-65-9Available(3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one
EMPA-0081204220-63-2Available(2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
EMPA-009864070-37-1Available(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
EMPA-010219823-47-9Available(R)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate
EMPA-01190-80-2Available(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-one
OptimisedRoute 3Steps 5 · Total yield 0.2 g
Synthetic routes & intermediates Route 3
CodeCAS No.Intermediate
EMPA-00732384-65-9Available(3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one
EMPA-020189628-37-3Available(S)-3-(4-bromophenoxy)tetrahydrofuran
EMPA-021857854-82-1Available5-bromo-2-chlorobenzaldehyde
EMPA-0221800196-43-3Available(5-bromo-2-chlorophenyl)(4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)methanol
EMPA-0231800196-44-4Available((5-bromo-2-chlorophenyl)(4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)methoxy)trimethylsilane
EMPA-024-(2S,3R,4S,5R,6R)-2-(4-chloro-3-((4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)((trimethylsilyl)oxy)methyl)phenyl)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-ol
EMPA-0251800196-50-2Available(2S,3R,4S,5S,6R)-2-(4-chloro-3-(methoxy(4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
ProcessRoute 2Steps 6 · Total yield 211 kg
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
EMPA-00732384-65-9Available(3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one
EMPA-01219094-56-5Available2-chloro-5-iodobenzoic acid
EMPA-013462-06-6Availablefluorobenzene
EMPA-014915095-86-2Available(2-chloro-5-iodophenyl)(4-fluorophenyl)methanone
EMPA-01586087-23-2Available(S)-tetrahydrofuran-3-ol
EMPA-016915095-87-3Available(S)-(2-chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone
EMPA-017915095-94-2Available(S)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)tetrahydrofuran
EMPA-0181637561-74-0Available(2S,3R,4S,5R,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-ol
EMPA-0191279691-36-9Available(2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

Frequently asked questions

What are the approved indications of Empagliflozin?

Approved indications include: 慢性肾功能不全, 心脏衰竭, 二型糖尿病.

When does the Empagliflozin patent expire?

Based on public sources, the Empagliflozin patent expires in 2028.

How many synthesis routes are recorded for Empagliflozin?

3 synthesis routes are recorded; the shortest is 5 steps with 0.2 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Empagliflozin intermediates?

24 intermediate CAS of Empagliflozin are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Empagliflozin intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24